Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer

Kurt, Ender; Kurt, MERAL; Kanat, Ozkan; Cetintas, SİBEL; Aygun, Sevilcan; Palazoglu, Julay; Ozkan, Lutfi; Evrensel, TÜRKKAN; Kaya, EKREM; Manavoglu, Osman

doi:10.1177/030089160609200603

Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer

Copy For Citation

Kurt E., Kurt M., Kanat O., Cetintas S., Aygun S., Palazoglu J., ...More

TUMORI, vol.92, no.6, pp.481-486, 2006 (SCI-Expanded)

Publication Type: Article / Article
Volume: 92 Issue: 6
Publication Date: 2006
Doi Number: 10.1177/030089160609200603
Journal Name: TUMORI
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.481-486
Bursa Uludag University Affiliated: Yes

Abstract

Aims and background: To evaluate the efficacy and tolerability of a new treatment approach including induction chemotherapy (CT) and concurrent chemoradiotherapy (CRT) in unresectable, locally advanced pancreatic cancer (LAPC).